Puretech Health PLC (PRTC) Receives Buy Rating from Peel Hunt

Peel Hunt reissued their buy rating on shares of Puretech Health PLC (LON:PRTC) in a research report sent to investors on Friday. They currently have a GBX 259 ($3.20) target price on the stock.

PRTC has been the subject of several other reports. Liberum Capital reissued a buy rating and set a GBX 248 ($3.06) target price on shares of Puretech Health PLC in a research report on Wednesday, December 21st. Jefferies Group LLC reissued a buy rating and set a GBX 255 ($3.15) target price on shares of Puretech Health PLC in a research report on Monday, December 12th. Numis Securities Ltd reissued a buy rating and set a GBX 220 ($2.72) target price on shares of Puretech Health PLC in a research report on Thursday, December 15th. Finally, N+1 Singer reissued a buy rating and set a GBX 243 ($3.00) target price on shares of Puretech Health PLC in a research report on Wednesday, December 21st. Five analysts have rated the stock with a buy rating, The stock has a consensus rating of Buy and a consensus price target of GBX 245 ($3.03).

Analyst Recommendations for Puretech Health PLC (LON:PRTC)

Shares of Puretech Health PLC (LON:PRTC) traded up 0.64% during mid-day trading on Friday, reaching GBX 117.25. The company’s stock had a trading volume of 5,593 shares. Puretech Health PLC has a 12 month low of GBX 110.00 and a 12 month high of GBX 170.00. The firm’s market capitalization is GBX 269.49 million. The company has a 50 day moving average of GBX 114.71 and a 200-day moving average of GBX 128.47.

ILLEGAL ACTIVITY NOTICE: “Puretech Health PLC (PRTC) Receives Buy Rating from Peel Hunt” was posted by Mideast Time and is owned by of Mideast Time. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.mideasttime.com/puretech-health-plc-prtc-receives-buy-rating-from-peel-hunt/1589359.html.

About Puretech Health PLC

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.

Receive News & Ratings for Puretech Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health PLC and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.